Delineation of a deletion region critical for corpus callosal abnormalities in chromosome 1q43-q44

European Journal of Human Genetics

Volumn 20, Issue 2, 2012, Pages 176-179

  Nagamani, Sandesh C Sreenath ^a   Erez, Ayelet ^a   Bay, Carolyn ^b   Pettigrew, Anjana ^c   Lalani, Seema R ^a   Herman, Kristin ^d   Graham, Brett H ^a   Nowaczyk, Malgorzata J M ^e   Proud, Monica ^a   Craigen, William J ^a   Hopkins, Bobbi ^a   Kozel, Beth ^f   Plunkett, Katie ^a   Hixson, Patricia ^a   Stankiewicz, Pawel ^a   Patel, Ankita ^a   Cheung, Sau Wai ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

1q43 44 deletion; agenesis of corpus callosum; AKT3; CEP170; corpus callosal abnormalities; ZNF238

Indexed keywords

ADOLESCENT; AKT3 GENE; ARTICLE; CEP170 GENE; CHILD; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; CORPUS CALLOSUM; FEMALE; GENE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SDCCAG8 GENE; ZNF238 GENE;

ADOLESCENT; AGENESIS OF CORPUS CALLOSUM; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE ORDER; HUMANS; INFANT; MALE;

EID: 84855806403     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2011.171     Document Type: Article

References (21)

1. van Bon BWM, Koolen DA, Borgatti R et al: Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis. J Med Genet 2008; 45: 346.
2. van Bever Y, Rooms L, Laridon A et al: Clinical report of a pure subtelomeric 1qter deletion in a boy with mental retardation and multiple anomalies adds further evidence for a specific phenotype. Am J Med Genet A 2005; 135: 91-95. (Pubitemid 40627672)
3. Merritt II JL, Zou Y, Jalal SM, Michels VV: Delineation of the cryptic 1qter deletion phenotype. Am J Med Genet A 2007; 143: 599-603. (Pubitemid 46348903)
4. Roberts AE, Cox GF, Kimonis V, Lamb A, Irons M: Clinical presentation of 13 patients with subtelomeric rearrangements and a review of the literature. Am J Med Genet A 2004; 128A: 352-363. (Pubitemid 38988636)
5. Hill AD, Chang BS, Hill RS et al: A 2-Mb critical region implicated in the microcephaly associated with terminal 1q deletion syndrome. Am J Med Genet A 2007; 143A: 1692-1698. (Pubitemid 47224691)
6. Caliebe A, Kroes HY, van der Smagt JJ et al: Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene. Eur J Med Genet 2010; 53: 179-185.
7. Orellana C, Rosello M, Monfort S et al: Corpus callosum abnormalities and the controversy about the candidate genes located in 1q44. Cytogenet Genome Res 2009; 127: 5-8.
8. Boland E, Clayton-Smith J, Woo VG et al: Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. Am J Hum Genet 2007; 81: 292.
9. Poot M, Kroes HY, VD Wijst SE et al: Dandy-Walker complex in a boy with a 5 Mb deletion of region 1q44 due to a paternal t(1;20)(q44;q13.33). Am J Med Genet A 2007; 143A: 1038-1044. (Pubitemid 46709273)
10. Poot M, Kroes HY, Hochstenbach R: AKT3 as a candidate gene for corpus callosum anomalies in patients with 1q44 deletions. Eur J Med Genet 2008; 51: 689.
11. Bi W, Sapir T, Shchelochkov OA et al: Increased LIS1 expression affects human and mouse brain development. Nat Genet 2009; 41: 168-177.
12. El-Hattab AW, Smolarek TA, Walker ME et al: Redefined genomic architecture in 15q24 directed by patient deletion/duplication breakpoint mapping. Hum Genet 2009; 126: 589-602.
13. Probst FJ, Roeder ER, Enciso VB et al: Chromosomal microarray analysis (CMA) detects a large X chromosome deletion including FMR1, FMR2, and IDS in a female patient with mental retardation. Am J Med Genet A 2007; 143A: 1358-1365. (Pubitemid 46870105)
14. O'Driscoll MC, Black GC, Clayton-Smith J, Sherr EH, Dobyns WB: Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A 2010; 152A: 2145-2159.
15. Easton RM, Cho H, Roovers K et al: Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 2005; 25: 1869-1878. (Pubitemid 40280150)
16. Tschopp O, Yang ZZ, Brodbeck D et al: Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 2005; 132: 2943-2954. (Pubitemid 41086730)
17. Guernsey DL, Jiang H, Hussin J et al: Mutations in centrosomal protein CEP152 in primary microcephaly families linked to MCPH4. Am J Hum Genet 2010; 87: 40-51.
18. Popesco MC, Maclaren EJ, Hopkins J et al: Human lineage-specific amplification, selection, and neuronal expression of DUF1220 domains. Science 2006; 313: 1304-1307. (Pubitemid 44330957)
19. de Anda FC, Meletis K, Ge X, Rei D, Tsai LH: Centrosome motility is essential for initial axon formation in the neocortex. J Neurosci 2010; 30: 10391-10406.
20. Aoki K, Meng G, Suzuki K et al: RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repression. J Biol Chem 1998; 273: 26698-26704. (Pubitemid 28471685)
21. Okado H, Ohtaka-Maruyama C, Sugitani Y et al: The transcriptional repressor RP58 is crucial for cell-division patterning and neuronal survival in the developing cortex. Dev Biol 2009; 331: 140-151.